Concepedia

Miriam Sant’Angelo

MS

4

Publications

254

Citations

4

H-Index

2019

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Bristol-Myers Squibb (United States)

Miriam Sant’Angelo is an author at Beth Israel Deaconess Medical Center specializing in prognostic biomarkers, tumor immunity, and predictive biomarkers.

ORCID

Top concepts

Publications per year

2019–2021

4

Publications

4

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Ziad Bakouny, David A. Braun, Sachet A. Shukla et al. · Nature Communications · 2021 · 154 citations · Full text

Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma

Miriam Ficial, Opeyemi A. Jegede, Miriam Sant’Angelo et al. · Clinical Cancer Research · 2020 · 78 citations · Full text

Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial.

Miriam Ficial, Opeyemi A. Jegede, Miriam Sant’Angelo et al. · Journal of Clinical Oncology · 2020 · 12 citations

, , +22

Spontaneous pneumothorax in cocaine users

Paola Ciriaco, Francesca Rossetti, Angelo Carretta et al. · QJM · 2019 · 10 citations · Full text

Rows per page

1–4 of 4